Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
					 Irinotecan (CPT11) SN-38 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 2.00 - 2,000 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | Heparin | 
| Storage Temperature (°C): | -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-NL | 
| CLIA: | No | 
| Therapy Area: | Oncology | 
| Classification: | Drug Assays | 
					 Irinotecan (CTP11) SN-38 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 2 - 4,000 ng/mL 2 - 4,000 ng/mL  | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 | 
| Platform: | LC-MS/MS | 
| Site: | QPS-NL | 
| CLIA: | No | 
| Therapy Area: | Oncology | 
| Classification: | Drug Assays | 
					 Iron (total) 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 50.0 - 5000 ng/mL | 
| Sample Volume: | 0.05 mL | 
| Anti-Coagulant: | Lithium Heparin | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | ICP-MS | 
| Site: | QPS-NL | 
| CLIA: | |
| Therapy Area: | |
| Classification: | Drug Assays | 
					 Iron (total) Iron (free) 
									
				| Matrix: | Human Serum Ultrafiltrate | 
| Assay Range: | 2.00-5,000 ng/mL 2.00-150 ng/mL above native  | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | N.Ap. | 
| Storage Temperature (°C): | -20 | 
| Platform: | ICP-MS | 
| Site: | QPS-NL | 
| CLIA: | No | 
| Therapy Area: | N/A | 
| Classification: | Drug Assays | 
					 Iron (total)
Iron (free) 
									
				Iron (free)
| Matrix: | Human Serum | 
| Assay Range: | 2.00-5,000 ng/mL 2.00-150 ng/mL above native  | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | N.Ap. | 
| Storage Temperature (°C): | -20 | 
| Platform: | ICP-MS | 
| Site: | QPS-NL | 
| CLIA: | No | 
| Therapy Area: | N/A | 
| Classification: | Drug Assays | 
					 Isoniazid 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 10 -4000 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | Sodium Heaprin | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Taiwan | 
| CLIA: | No | 
| Therapy Area: | Antibiotic | 
| Classification: | Drug Assays | 
					 Isosorbide
Mononitrate 
									
				Mononitrate
| Matrix: | Human Plasma | 
| Assay Range: | 10 - 4,000 ng/mL | 
| Sample Volume: | 0.2 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Cardiovascular | 
| Classification: | Drug Assays | 
					 Itraconazole 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 1 - 500 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Delaware | 
| CLIA: | No | 
| Therapy Area: | Antifungal | 
| Classification: | Drug Assays | 
					 Itraconazole
Hydroxyl-Itraconazole 
									
				Hydroxyl-Itraconazole
| Matrix: | Human Plasma | 
| Assay Range: | 1 - 500 ng/mL 2 - 1,000 ng/mL  | 
| Sample Volume: | 0.2 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Delaware | 
| CLIA: | No | 
| Therapy Area: | Antifungal | 
| Classification: | Drug Assays | 
					 Ketoconazole 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 20 - 10,000 ng/mL | 
| Sample Volume: | 0.05 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Delaware | 
| CLIA: | No | 
| Therapy Area: | Antifungal | 
| Classification: | Drug Assays | 
					 Ketoprofen 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 50.0 - 15,000 ng/mL | 
| Sample Volume: | 0.5 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 | 
| Platform: | HPLC-UV | 
| Site: | QPS-NL | 
| CLIA: | No | 
| Therapy Area: | NSAID | 
| Classification: | Drug Assays | 
					 Ketorolac 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 20 - 4,000 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | Heparin | 
| Storage Temperature (°C): | -20 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Taiwan | 
| CLIA: | No | 
| Therapy Area: | Analgesic | 
| Classification: | Drug Assays | 
					 Kidney injury molecule 1 (KIM-1) 
									
				| Matrix: | Human Urine | 
| Assay Range: | 0.156 - 10.0 pg/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | N.Ap. | 
| Storage Temperature (°C): | -20 | 
| Platform: | ELISA | 
| Site: | QPS-NL | 
| CLIA: | No | 
| Therapy Area: | N/A | 
| Classification: | Biochemical Biomarkers | 
					 Kidney injury molecule 1 (KIM-1) 
									
				| Matrix: | Human Urine | 
| Assay Range: | 50.0 - 2,000 pg/mL | 
| Sample Volume: | 0.125 mL | 
| Anti-Coagulant: | N.Ap. | 
| Storage Temperature (°C): | -70 | 
| Platform: | ELISA | 
| Site: | QPS-Delaware | 
| CLIA: | No | 
| Therapy Area: | N/A | 
| Classification: | Biochemical Biomarkers | 
					 KRAS (35G>T, 35G>A, 34G>T, 34G>A, 38G>A) 
									
				| Matrix: | Human Whole Blood | 
| Assay Range: | N/A | 
| Sample Volume: | 0.2 mL | 
| Anti-Coagulant: | N.Ap. | 
| Storage Temperature (°C): | -80 | 
| Platform: | Pyrosequencing | 
| Site: | QPS-Delaware | 
| CLIA: | |
| Therapy Area: | |
| Classification: | Genomic Biomarkers | 
					 Lacosamide 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 40 - 12,000 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Anticonvulsant | 
| Classification: | Genomic Biomarkers | 
					 Lamivudine (3TC) Tenofovir (TFV) in presence of Dolutegravir (DTG), Efavirenz (EFV), and Emtricitabine (FTC) 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 15 - 6,000 ng/mL 2.5 - 1,000 ng/mL  | 
| Sample Volume: | 0.2 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Antiviral - HIV | 
| Classification: | Drug Assays | 
					 Lamivudine (3TC)
Tenofovir (TFV) 
									
				Tenofovir (TFV)
| Matrix: | Human Plasma | 
| Assay Range: | 15 - 5,000 ng/mL 2 - 650 ng/mL  | 
| Sample Volume: | 0.2 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Antiviral - HIV | 
| Classification: | Drug Assays | 
					 Lamivudine (3TC)
Zalcitabine (ddC) 
									
				Zalcitabine (ddC)
| Matrix: | Human Plasma | 
| Assay Range: | 1 - 1,000 ng/mL | 
| Sample Volume: | 0.05 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Delaware | 
| CLIA: | No | 
| Therapy Area: | Antiviral - HIV | 
| Classification: | Drug Assays | 
					 Lamotrigine 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 1 - 600 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Delaware | 
| CLIA: | No | 
| Therapy Area: | Anticonvulsant | 
| Classification: | Drug Assays | 
					 Lamotrigine 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 5 - 2,000 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Anticonvulsant | 
| Classification: | Drug Assays | 
					 Lamotrigine 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 5 - 4,000 ng/mL | 
| Sample Volume: | 0.2 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Anticonvulsant | 
| Classification: | Drug Assays | 
					 Lamotrigine 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 20 - 3,500 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Anticonvulsant | 
| Classification: | Drug Assays | 
					 Lamotrigine 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 5 - 1,000 ng/mL | 
| Sample Volume: | 0.1 mL | 
| Anti-Coagulant: | Heparin | 
| Storage Temperature (°C): | -20 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-Taiwan | 
| CLIA: | No | 
| Therapy Area: | Anticonvulsant | 
| Classification: | Drug Assays | 
					 Lansoprazole 
									
				| Matrix: | Human Plasma | 
| Assay Range: | 5 - 2,250 ng/mL | 
| Sample Volume: | 0.05 mL | 
| Anti-Coagulant: | EDTA | 
| Storage Temperature (°C): | -20 & -70 | 
| Platform: | LC/MS/MS | 
| Site: | QPS-India | 
| CLIA: | No | 
| Therapy Area: | Gastrointestinal | 
| Classification: | Drug Assays | 
Links to Relevant Documents
Testimonials
						Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!					
									
								QPS CLIENT